Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20071
20081
20091
20101
20122
20141
20161
20181
20221
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris6
Bayer1
CSL Behring1
Central Hospital, Nancy, France1
D-Pharm Ltd.1
H. Lundbeck A/S1
Institut National de la Santé Et de la Recherche Médicale, France1
Janssen Research & Development, LLC1
Joseph Broderick1
PhotoThera, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke19
Stroke12
Atherosclerosis3
Foramen Ovale, Patent3
Atrial Fibrillation2
Cerebral Infarction2
Cerebrovascular Disorders2
Heart Diseases2
Ischemic Attack, Transient2
Acute Coronary Syndrome1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.